Key result
Pulmonary hypertension is a global disease with diverse etiologies, affecting an estimated 80% of patients in the developing world, and should no longer be considered a rare orphan disease.
The article discusses the evolution of pulmonary hypertension from an orphan disease to a globally recognized condition with emerging medical therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ghazwan Butrous (2020) conducted a review in Pulmonary hypertension. Pulmonary hypertension was evaluated. Pulmonary hypertension is a global disease with diverse etiologies, affecting an estimated 80% of patients in the developing world, and should no longer be considered a rare orphan disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: